Ropes & Gray represented newly-launched Tortugas Neuroscience in equity financings led by Cure Ventures, The Column Group, and AN Ventures, and in strategic licensing deals with Jiangsu Hansoh Pharmaceutical Group and Eisai Co. Ltd.
Tortugas launched on April 21, 2026 with $106 million from Cure Ventures, The Column Group, and AN Ventures. The company plans to develop two schizophrenia and tinnitus drugs licensed from Hansoh, as well as medicines for focal epilepsy and encephalopathies originally created by Eisai.
The Ropes & Gray team was led by emerging companies & venture capital and life sciences licensing partner Rajarshi Banerjee, capital markets partner Will Michener, life sciences licensing associate Peter Chi, and emerging companies & venture capital associate Yahel Kaplan.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.